Dennis Patrick Molnar - 30 Jul 2026 Form 3 Insider Report for Apnimed, Inc. (APMD)

Reporting relationship: President and COO
Issuer ticker: APMD
Reported as of: 30 Jul 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 30 Jul 2026, 16:34:30 UTC
Source filing: View source filing
Reporting owner signature: /s/Kevin R. Lind, Attorney-in-Fact

Key filing fact

Dennis Patrick Molnar filed Form 3 for Apnimed, Inc. (APMD) on 30 Jul 2026.

Key facts

This page summarizes Dennis Patrick Molnar's Form 3 filing for Apnimed, Inc. (APMD).
0 reported transactions and 7 derivative rows are listed below.
Accepted by SEC: 30 Jul 2026, 16:34.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001822371 Primary reporting owner

Molnar Dennis Patrick

Relationship: President and COO
Address: APNIMED, INC., 39 JOHN F. KENNEDY STREET, 4TH FLOOR., CAMBRIDGE
Signature: /s/Kevin R. Lind, Attorney-in-Fact
Signature date: 30 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APMD holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 58,014
Date: 30 Jul 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APMD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Jul 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 330,210
Exercise price: $1.00
Footnotes: F1

APMD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Jul 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 42,240
Exercise price: $1.00
Footnotes: F1

APMD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Jul 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 148,788
Exercise price: $1.06
Footnotes: F1

APMD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Jul 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 37,064
Exercise price: $2.74
Footnotes: F1

APMD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Jul 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 28,539
Exercise price: $4.00
Footnotes: F2

APMD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Jul 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 37,064
Exercise price: $4.87
Footnotes: F3

APMD holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 30 Jul 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 12,231
Exercise price: $8.88
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

100% of the shares subject to such option are fully vested.

Footnote F2

25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 22, 2022, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Footnote F3

25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 21, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Footnote F4

25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 17, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .